Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300

Go back to Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
(NYSE: BHVN) Delayed: 11.28 -0.09 (0.79%)
Previous Close $11.37    52 Week High
Open $11.43    52 Week Low
Day High $11.99    P/E N/A 
Day Low $11.26    EPS
Volume 2,360,169